Standex (SXI) director Thomas Chorman sells 50 shares under 10b5-1 plan

Rhea-AI Filing Summary

Standex International director Thomas E. Chorman reported an open-market sale of 50 shares of Standex International common stock at $259 per share on March 2, 2026. The sale was made under an existing Rule 10b5-1 trading plan dated November 6, 2025, and he now holds 12,616 shares directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CHORMAN THOMAS E

(Last) (First) (Middle)

STANDEX INTERNATIONAL CORPORATION

23 KEEWAYDIN DRIVE, SUITE 300

(Street)

SALEM NH 03079

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STANDEX INTERNATIONAL CORP/DE/ [ SXI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		S(1)		50	D	$259	12,616	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale of stock pursuant to existing 10b5-1 trading plan dated November 6, 2025.

	/s/ Alan J. Glass	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Standex International (SXI) report for Thomas E. Chorman?

Standex International reported that director Thomas E. Chorman sold 50 shares of common stock. The shares were sold at $259 each in an open-market transaction, reflecting a small portion of his direct holdings in the company.

At what price did Thomas E. Chorman sell Standex International (SXI) shares?

Thomas E. Chorman sold his Standex International shares at $259 per share. This price applied to 50 shares of common stock sold in a single open-market transaction reported in the Form 4 insider trading disclosure.

How many Standex International (SXI) shares does Thomas E. Chorman own after the sale?

After the reported transaction, Thomas E. Chorman directly owns 12,616 shares of Standex International common stock. This remaining balance reflects his holdings following the open-market sale of 50 shares disclosed in the Form 4 filing.

Was the Standex International (SXI) share sale by Thomas E. Chorman under a 10b5-1 plan?

Yes, the share sale by Thomas E. Chorman was executed under an existing Rule 10b5-1 trading plan. The plan was dated November 6, 2025, and prearranged the stock sale independently of day-to-day market conditions.

What type of transaction did Thomas E. Chorman execute in Standex International (SXI) stock?

Thomas E. Chorman executed an open-market sale of Standex International common stock. The Form 4 describes the transaction as a non-derivative sale of 50 shares at $259 per share, reducing but not eliminating his direct equity position.

What does the Form 4 for Standex International (SXI) indicate about net insider activity?

The Form 4 indicates net selling activity by Thomas E. Chorman, with 50 shares sold and no purchases reported. This results in a net change of minus 50 shares, while he continues to hold 12,616 shares directly in the company.